U.S. Retail Distributors Stock News

Why First Busey (BUSE) Is Back on Investors’ Radar First Busey (BUSE) has attracted fresh attention after releasing fourth quarter and full year 2025 results, a leadership change, and an update on its long running share repurchase program. See our latest analysis for First Busey. The earnings release, leadership change and share repurchase update have come alongside a 12.27% 90 day share price return and a 39.40% five year total shareholder return, suggesting momentum has been building...

Louisiana-Pacific Corporation has announced that, effective February 19, 2026, long-time director F. Nicholas Grasberger III will become independent Chairperson as current Chair and CEO W. Bradley Southern retires from the Board, while President and CEO-elect Jason P. Ringblom joins as a Class III director and two other directors plan to retire in May 2026. This leadership reshaping, pairing an independent Chair with an internal successor as CEO, signals a clearer separation of oversight and...

The Beachbody Company, Inc. ( NASDAQ:BODI ) shares have continued their recent momentum with a 31% gain in the last...

If you are wondering whether NIKE's current share price offers genuine value or just looks cheap on the surface, this article is designed to walk you through the key numbers in a clear and practical way. NIKE shares last closed at US$62.18, with returns of 4.3% decline over 7 days, 1.7% decline over 30 days, 1.7% decline year to date, 16.9% decline over 1 year, 47.8% decline over 3 years and 53.4% decline over 5 years. This raises questions about how the market is currently viewing its...

Analyst optimism and product pipeline in focus Krystal Biotech (KRYS) is back in the spotlight after several major research houses highlighted its potential to evolve into a multi product company, pointing to ophthalmic candidates KB803 and KB801 and the planned geographic expansion of Vyjuvek. See our latest analysis for Krystal Biotech. Those upbeat analyst views have landed alongside strong recent momentum, with Krystal Biotech’s share price at $282.27 and a 30 day share price return of...

If you are wondering whether Rocket Lab shares still offer value after a strong run, it helps to step back and consider what the current price might already be taking into account. The stock has seen a 161.3% return over the past year and a very large return over three years. However, over the last 7 days and 30 days it has shown declines of 7.9% and 2.4%, respectively. Recent attention has centered on Rocket Lab's role as a listed space company and ongoing interest in space-related...

Penguin Solutions has announced that long-time leader Mark Adams has retired as President, Chief Executive Officer and Director, with technology veteran Kash Shaikh stepping in as President, CEO, principal executive officer and Board member effective February 2, 2026, while Adams remains an advisor for nine months to support the transition. Shaikh’s three-decade career across enterprise software, SaaS, AI infrastructure and cybersecurity, most recently as CEO of Securonix and Virtana,...

Li Auto Inc. reported that it delivered 27,668 vehicles in January 2026, bringing its cumulative deliveries to 1,567,883 as the company rolled out an OTA 8.2 software update and continued expanding its nationwide retail and supercharging network in China. The latest data highlight ongoing sales pressure, with January marking the eighth consecutive month of year-on-year delivery declines even as Li Auto restructures R&D and pushes into pure-electric models and humanoid robotics. Next, we...

FirstSun Capital Bancorp recently reported full-year 2025 results showing net interest income rising to US$317.39 million and net income increasing to US$97.94 million, alongside higher earnings per share, while also recording fourth-quarter net charge-offs of US$5.02 million. At the same time, the board is set for change as long-serving director Diane L. Merdian plans to step down and investor Peter E. Murphy, founder and CEO of Wentworth Capital Management, joins as a Class III director...

In late January 2026, Olema Pharmaceuticals announced the departure of Chief Operating and Financial Officer Shane Kovacs, with CEO Dr. Sean P. Bohen stepping in as interim Principal Financial Officer while the company launches an immediate search for a new CFO and retains Kovacs as a consultant through August 1, 2026. At the same time, analysts underscored the importance of Olema’s lead breast cancer candidate palazestrant and its upcoming Phase 3 program, framing leadership changes against...

American Assets Trust (AAT) is on some investors’ radar after recent share price moves, with the stock last closing at $18.03 as they reassess this real estate investment trust’s long term return profile. See our latest analysis for American Assets Trust. Recent trading has been a bit choppy, with a small 7 day share price return of 1.18% set against a 90 day share price return decline of 5.01% and a 1 year total shareholder return decline of 20.11%. This suggests that sentiment has softened...

Textron (TXT) just paired a strong fourth quarter of 2025 with a cautious 2026 outlook, a combination that has put the stock under pressure as investors reassess the risk and reward trade off. See our latest analysis for Textron. That cautious 2026 guidance has weighed on sentiment in the short term, with a 7 day share price return of 7.48% decline following the results, even though the 90 day share price return of 9.78% and 1 year total shareholder return of 16.20% still point to momentum...

For investors considering whether Synchrony Financial at around US$73.52 offers genuine value or if the easy money has already been made, this article walks through what the current price might be indicating. The stock has seen a 5.1% decline over the last 7 days and a 13.1% decline over the last 30 days, although it still shows a 10.4% return over 1 year and very large gains of more than 7x over 5 years. These recent moves sit against a backdrop of ongoing updates around consumer credit...

BigBear.ai Holdings (NYSE:BBAI) has partnered with Maqta Technologies, the digital arm of Abu Dhabi’s AD Ports Group. The two firms plan to co-develop AI driven customs and border management solutions for global trade and port operations. The agreement signals BigBear.ai’s push beyond its core U.S. defense focus into broader international government technology programs. For investors watching NYSE:BBAI, this partnership comes as the shares trade at $4.78, with a 1 year return of 13.0% but...

Customers Bancorp (CUBI) is back on investors’ radar after reporting fourth quarter and full year 2025 results alongside 2026 guidance, highlighting net interest income, net income and earnings per share figures that reshape expectations. See our latest analysis for Customers Bancorp. Those earnings and 2026 net interest income guidance landed alongside a steady run in the market, with a 30 day share price return of 6.82% and a 90 day share price return of 18.90%. The 1 year total shareholder...

Unfortunately for some shareholders, the Bitcoin Depot Inc. ( NASDAQ:BTM ) share price has dived 30% in the last thirty...

Why the latest earnings matter for Minerals Technologies stock Minerals Technologies (MTX) has come back into focus after releasing its Q4 and full year 2025 results, which combined a full year net loss with record outcomes in key operating segments and fresh guidance for 2026. See our latest analysis for Minerals Technologies. The share price reaction has been fairly constructive, with a 21.02% 90 day share price return and 10.06% year to date, even though the 1 year total shareholder return...

Blackstone stock overview Blackstone (BX) is in focus for investors after a recent stretch of weaker share performance, with the stock showing declines over the past week, month, and past 3 months compared with its last close of $141.28. See our latest analysis for Blackstone. The recent 7 day and 30 day share price returns, which show declines of 5.86% and 11.03%, point to fading short term momentum. In contrast, the 3 year and 5 year total shareholder returns of 60.14% and 134.77% highlight...

Labcorp Holdings recently executed a second amendment to its receivables purchase agreement, extending the facility’s termination date to January 26, 2029 and adding an accordion feature that can lift its size from US$700 million to US$825 million. This extension and potential expansion of receivables financing gives Labcorp additional liquidity flexibility while keeping the structure separate from traditional on-balance-sheet borrowing. With this expanded receivables facility enhancing...

Ellington Financial (EFC) has drawn fresh attention after completing a US$118.46 million follow on common stock offering and releasing an updated estimated book value per share alongside ongoing monthly dividend payments. See our latest analysis for Ellington Financial. At a share price of US$12.66, Ellington Financial has seen a 1 day share price return of a 1.48% decline and a 7 day share price return of an 8.66% decline. However, its 1 year total shareholder return of 13.75% and 5 year...

If you are wondering whether Palomar Holdings at around US$124 per share still offers value, this article walks through what the current price might be implying. The stock has eased back recently, with a 2.2% decline over the last week and a 5.8% decline over the last month. However, the 1 year return sits at 16.1% and the 3 year return is very large at about 7x. Recent coverage around Palomar has focused on the company's position in specialty insurance and how investors are reacting to...

Lam Research (NasdaqGS:LRCX) announced a multi year collaboration with CEA Leti to accelerate next generation specialty device technologies for AI and high performance computing. The partnership focuses on advanced fabrication processes and novel materials for applications in AI, photonics, MEMS, and quantum technologies. The alliance combines Lam’s etch and deposition capabilities with CEA Leti’s research expertise to address manufacturing challenges in future chip architectures. For you...

Hanover Bancorp, Inc.'s ( NASDAQ:HNVR ) investors are due to receive a payment of $0.10 per share on 26th of February...

Why the FDA’s Complete Response Letter Matters for Aquestive Aquestive Therapeutics (AQST) has drawn fresh attention after the FDA issued a Complete Response Letter for its Anaphylm epinephrine sublingual film, prompting the company to schedule a special call to discuss the regulatory feedback. See our latest analysis for Aquestive Therapeutics. The FDA letter appears to have been the catalyst for a sharp shift in sentiment, with a 1 day share price return of 38.98% and a 7 day share price...